University of Vermont

The University of Vermont Cancer Center

This page has moved to here!

Other Solid Tumors Clinical Trials

The University of Vermont Cancer Center has many trials specifically focused on solid tumor research.

Status: Active - Recruiting
Study Title: Phase I, First-in-Human, Dose Escalation Trial of MSC2363318A, a Dual p70S6K/Akt Inhibitor, in Subjects with Advanced Malignancies
Purpose: This is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity signals of MSC2363318A.
ClinicalTrials.gov Identifier: NCT01971515
Primary/Site/Co Investigator:
Contact: Sam Cory (802)-656-9446
Information: http://www.clinicaltrials.gov/ct2/show/NCT01971515?term=01971515&rank=1
Institution Number: CHRMS 14-081
Protocol Research Type: Industry Sponsored
Status: Active - Recruiting
Study Title: EMR100070-001: A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications.
Purpose: This is a Phase 1, open-label, dose-escalation trial of MSB0010718C [antibody targeting programmed death ligand 1 (anti PD-L1)] with consecutive parallel group expansion in subjects with selected tumor indications.
ClinicalTrials.gov Identifier: NCT01772004
Primary/Site/Co Investigator:
Contact: Sam Cory (802)-656-9446
Information: http://www.clinicaltrials.gov/ct2/show/NCT01772004?term=NCT01772004&rank=1
Institution Number: CHRMS 14-240
Protocol Research Type: Industry Sponsored

Last modified December 02 2016 09:42 AM